Viagenpumatucel-L: Phase Ib started

Heat Biologics began the open-label, U.S. Phase Ib DURGA trial to evaluate weekly intradermal viagenpumatucel-L in combination with multiple immune treatments for 18 weeks in about 27 patients. Treatm...